Rachel M Koldej (Rachel Koldej)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Chronic Lymphocytic Leukemia

Stem Cell Transplantation

Top Venues

Bone marrow transplantation

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Sasanka Mithila Handunnetti, Mary Ann Anderson, Kate I Burbury, Phillip A Thompson, Glenda Burke, Mathias Bressel, Juliana L Di Iulio, Rodney John Hicks, David A Westerman, Stephen Lade, Christiane Pott, Rishu Agarwal, Rachel M Koldej, David Ritchie, Martin Dreyling, Mark A Dawson, Sarah-Jane Dawson, John Francis Seymour, Andrew W Roberts, Constantine S Tam
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions. Blood (2024)
Ray Mun Koo, Eric Wong, Joanne E Davis, Travis Perera, Andrew Lim, Rachel M Koldej, David S Ritchie
A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome. Bone marrow transplantation (2024)
Sasanka Mithila Handunnetti, Mary Ann Anderson, Kate I Burbury, Phillip A Thompson, Glenda Burke, Mathias Bressel, Juliana Di Iulio, Rodney John Hicks, David Westerman, Stephen Lade, Christiane Pott, Rishu Agarwal, Rachel M Koldej, David S Ritchie, Martin Dreyling, Mark A Dawson, Sarah-Jane Dawson, John Francis Seymour, Andrew W Roberts, Constantine S Tam
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions. Blood 144 (8) (2024)
Ray Mun Koo, Eric Wong, Joanne E Davis, Travis Perera, Andrew Lim, Rachel M Koldej, David S Ritchie
A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome. Bone marrow transplantation 59 (7) (2024)
Ray Mun Koo, Eric Wong, Joanne E Davis, Travis Perera, Andrew Lim, Rachel M Koldej, David S Ritchie
A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome. Bone marrow transplantation 59 (7) (2024)
Adrian G Minson, Nada Hamad, Chan Yoon Y Cheah, Constantine S Tam, Piers Blombery, David A Westerman, David S Ritchie, Huw Morgan, Nicholas Holzwart, Stephen Lade, Mary Ann Anderson, Amit Khot, John Francis Seymour, Molly Robertson, Imogen Caldwell, Georgina L Ryland, Javad Saghebi, Zahra Sabahi, Jing Xie, Rachel M Koldej, Michael J Dickinson
CAR T-cells and Time-Limited Ibrutinib as Treatment for Relapsed/Refractory Mantle Cell Lymphoma: Phase II TARMAC Study. Blood (2023)
Lavinia Tan, Ben Tran, Jeanne Tie, Benjamin Markman, Sumi Ananda, Niall C Tebbutt, Michael Michael, Emma Link, Stephen Q Wong, Sushma Chandrashekar, Jerick Guinto, David S Ritchie, Rachel M Koldej, Benjamin J Solomon, Grant A McArthur, Rodney John Hicks, Peter Gibbs, Sarah-Jane Dawson, Jayesh Desai
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Lavinia Tan, Ben Tran, Jeanne Tie, Benjamin Markman, Sumi Ananda, Niall C Tebbutt, Michael Michael, Emma Link, Stephen Q Wong, Sushma Chandrashekar, Jerick Guinto, David S Ritchie, Rachel M Koldej, Benjamin J Solomon, Grant A McArthur, Rodney John Hicks, Peter Gibbs, Sarah-Jane Dawson, Jayesh Desai
Phase Ib/II Trial of BRAF and EGFR inhibition in BRAFV600E metastatic colorectal cancer and other cancers: EVICT (Erlotinib and Vemurafenib In Combination Trial). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Lavinia Tan, Ben Tran, Jeanne Tie, Benjamin Markman, Sumi Ananda, Niall C Tebbutt, Michael Michael, Emma Link, Stephen Q Wong, Sushma Chandrashekar, Jerick Guinto, David S Ritchie, Rachel M Koldej, Benjamin J Solomon, Grant A McArthur, Rodney John Hicks, Peter Gibbs, Sarah-Jane Dawson, Jayesh Desai
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Ashvind A Prabahran, Rachel M Koldej, Lynette Chee, Jeffrey Szer, David Ritchie
Non-relapse cytopenias following allogeneic stem cell transplantation, a case based review. Bone marrow transplantation 57 (10) (2022)
Ashvind A Prabahran, Rachel M Koldej, Lynette Chee, David S Ritchie
Clinical features, pathophysiology and therapy of Poor Graft Function Post Allogeneic Stem Cell Transplantation. Blood advances (2021)
James A Kuzich, Yamuna Kankanige, Jerick Guinto, Georgina Ryland, Michelle McBean, Eric Wong, Rachel M Koldej, Jenny Collins, David Westerman, David Ritchie, Piers Blombery
T cell receptor beta locus sequencing early post-allogeneic stem cell transplant identifies patients at risk of initial and recurrent cytomegalovirus infection. Bone marrow transplantation 56 (10) (2021)